Komori
Governance4564OncoTherapy Science,Inc.Pharmaceuticals

Notice Regarding Membership Status in the Financial Accounting Standards Foundation and the Company’s Views on Membership

The Company disclosed that it is not a member of the Financial Accounting Standards Foundation and has no plans to join at this stage. It gathers information on accounting standards and responds to changes by attending seminars and working with its audit firm, among other measures.

Worth reading
—
Scored from 0 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Contents of this filing

Changes this time

The Company disclosed that it is not a member of the Financial Accounting Standards Foundation and has no plans to join at this stage. The disclosure does not state whether this represents a change from the previous disclosure.

この書類は、機関設計や取締役会の構成そのものは述べていません。上に示したのは、この書類が述べている変更点です。

Contents of this filing
ItemDetails
Changes this timeThe Company disclosed that it is not a member of the Financial Accounting Standards Foundation and has no plans to join at this stage. The disclosure does not state whether this represents a change from the previous disclosure.
Items this document does not state (7)
Corporate Governance StructureNumber of directorsNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company recognizes the importance of understanding the details of accounting standards and responding appropriately to changes. It has established a framework for doing so through various seminars, coordination with its audit firm, information provided by specialist firms, and subscriptions to professional publications. The Company did not expressly state why it is not a member.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Membership Status in the Financial Accounting Standards Foundation and the Company’s Views on Membership | OncoTherapy Science,Inc. (4564) timely disclosure | Komori